MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans

The target of any immunization is to activate and expand lymphocyte clones with the desired recognition specificity and the necessary effector functions. In gene, recombinant and peptide vaccines, the immunogen is a single protein or a small assembly of epitopes from antigenic proteins. Since most i...

Full description

Bibliographic Details
Main Author: Cunha-Neto E.
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 1999-01-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1999000200008
_version_ 1811327223600250880
author Cunha-Neto E.
author_facet Cunha-Neto E.
author_sort Cunha-Neto E.
collection DOAJ
description The target of any immunization is to activate and expand lymphocyte clones with the desired recognition specificity and the necessary effector functions. In gene, recombinant and peptide vaccines, the immunogen is a single protein or a small assembly of epitopes from antigenic proteins. Since most immune responses against protein and peptide antigens are T-cell dependent, the molecular target of such vaccines is to generate at least 50-100 complexes between MHC molecule and the antigenic peptide per antigen-presenting cell, sensitizing a T cell population of appropriate clonal size and effector characteristics. Thus, the immunobiology of antigen recognition by T cells must be taken into account when designing new generation peptide- or gene-based vaccines. Since T cell recognition is MHC-restricted, and given the wide polymorphism of the different MHC molecules, distinct epitopes may be recognized by different individuals in the population. Therefore, the issue of whether immunization will be effective in inducing a protective immune response, covering the entire target population, becomes an important question. Many pathogens have evolved molecular mechanisms to escape recognition by the immune system by variation of antigenic protein sequences. In this short review, we will discuss the several concepts related to selection of amino acid sequences to be included in DNA and peptide vaccines.
first_indexed 2024-04-13T15:02:57Z
format Article
id doaj.art-0a1b2f9dba16407eba528c86358e1c07
institution Directory Open Access Journal
issn 0100-879X
0034-7310
language English
last_indexed 2024-04-13T15:02:57Z
publishDate 1999-01-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-0a1b2f9dba16407eba528c86358e1c072022-12-22T02:42:14ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X0034-73101999-01-01322MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humansCunha-Neto E.The target of any immunization is to activate and expand lymphocyte clones with the desired recognition specificity and the necessary effector functions. In gene, recombinant and peptide vaccines, the immunogen is a single protein or a small assembly of epitopes from antigenic proteins. Since most immune responses against protein and peptide antigens are T-cell dependent, the molecular target of such vaccines is to generate at least 50-100 complexes between MHC molecule and the antigenic peptide per antigen-presenting cell, sensitizing a T cell population of appropriate clonal size and effector characteristics. Thus, the immunobiology of antigen recognition by T cells must be taken into account when designing new generation peptide- or gene-based vaccines. Since T cell recognition is MHC-restricted, and given the wide polymorphism of the different MHC molecules, distinct epitopes may be recognized by different individuals in the population. Therefore, the issue of whether immunization will be effective in inducing a protective immune response, covering the entire target population, becomes an important question. Many pathogens have evolved molecular mechanisms to escape recognition by the immune system by variation of antigenic protein sequences. In this short review, we will discuss the several concepts related to selection of amino acid sequences to be included in DNA and peptide vaccines.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1999000200008vaccinesMHCantigen recognitionantigen processingT cellsmolecular evolution
spellingShingle Cunha-Neto E.
MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans
Brazilian Journal of Medical and Biological Research
vaccines
MHC
antigen recognition
antigen processing
T cells
molecular evolution
title MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans
title_full MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans
title_fullStr MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans
title_full_unstemmed MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans
title_short MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans
title_sort mhc restricted antigen presentation and recognition constraints on gene recombinant and peptide vaccines in humans
topic vaccines
MHC
antigen recognition
antigen processing
T cells
molecular evolution
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1999000200008
work_keys_str_mv AT cunhanetoe mhcrestrictedantigenpresentationandrecognitionconstraintsongenerecombinantandpeptidevaccinesinhumans